Free Trial
NASDAQ:ATNF

180 Life Sciences (ATNF) Stock Price, News & Analysis

180 Life Sciences logo
$2.28 -0.06 (-2.56%)
(As of 11/21/2024 ET)

About 180 Life Sciences Stock (NASDAQ:ATNF)

Key Stats

Today's Range
$2.21
$2.45
50-Day Range
$1.18
$6.47
52-Week Range
$1.16
$17.75
Volume
107,755 shs
Average Volume
785,906 shs
Market Capitalization
$2.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.

180 Life Sciences Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
6th Percentile Overall Score

ATNF MarketRank™: 

180 Life Sciences scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for 180 Life Sciences.

  • Price to Book Value per Share Ratio

    180 Life Sciences has a P/B Ratio of 0.63. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    28.45% of the float of 180 Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    180 Life Sciences has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in 180 Life Sciences has recently increased by 77.13%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    180 Life Sciences does not currently pay a dividend.

  • Dividend Growth

    180 Life Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    28.45% of the float of 180 Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    180 Life Sciences has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in 180 Life Sciences has recently increased by 77.13%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    180 Life Sciences has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for 180 Life Sciences this week, compared to 0 articles on an average week.
  • Search Interest

    Only 3 people have searched for ATNF on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added 180 Life Sciences to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, 180 Life Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.17% of the stock of 180 Life Sciences is held by insiders.

  • Percentage Held by Institutions

    Only 4.07% of the stock of 180 Life Sciences is held by institutions.

  • Read more about 180 Life Sciences' insider trading history.
Receive ATNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

ATNF Stock News Headlines

180 Life Sciences files to sell 1.9M shares of common stock for holders
Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
Elray Resources Announces Strategic Sale of Crypto iGaming Technology
See More Headlines

ATNF Stock Analysis - Frequently Asked Questions

180 Life Sciences' stock was trading at $4.0565 at the start of the year. Since then, ATNF shares have decreased by 43.8% and is now trading at $2.28.
View the best growth stocks for 2024 here
.

Shares of 180 Life Sciences reverse split on Wednesday, February 28th 2024. The 1-19 reverse split was announced on Wednesday, February 28th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, February 28th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of ATNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that 180 Life Sciences investors own include Meta Platforms (META), NIO (NIO), Enterprise Products Partners (EPD), HubSpot (HUBS), Netflix (NFLX), Palantir Technologies (PLTR) and Plug Power (PLUG).

Company Calendar

Today
11/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ATNF
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-19,930,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$3.64 per share

Miscellaneous

Free Float
1,025,000
Market Cap
$2.35 million
Optionable
No Data
Beta
0.23
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:ATNF) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners